Day One Biopharmaceuticals, Inc.
DAWN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$95,496 | -$188,917 | -$142,181 | -$72,754 |
| Dep. & Amort. | $2,029 | $383 | $531 | $199 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $48,263 | $39,341 | $27,242 | $13,321 |
| Change in WC | $26,480 | $9,418 | $6,564 | $2,695 |
| Other Non-Cash | -$59,389 | -$7,078 | -$2,030 | $8,000 |
| Operating Cash Flow | -$78,113 | -$146,853 | -$109,874 | -$48,539 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,169 | -$224 | -$26 | -$8,000 |
| Net Acquisitions | $0 | $0 | $255 | $0 |
| Inv. Purchases | -$658,616 | -$443,838 | -$394,206 | $0 |
| Inv. Sales/Matur. | $393,891 | $575,440 | $139,158 | $0 |
| Other Inv. Act. | $35,900 | -$3,000 | -$255 | $0 |
| Investing Cash Flow | -$230,994 | $128,378 | -$255,074 | -$8,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $178,177 | $161,409 | $161,610 | $167,045 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $25,114 | $0 | $4,291 | $318 |
| Financing Cash Flow | $203,291 | $163,997 | $165,901 | $297,120 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$105,816 | $145,522 | -$199,047 | $240,581 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $230,784 | $85,262 | $284,309 | $43,728 |
| End Cash | $124,968 | $230,784 | $85,262 | $284,309 |
| Free Cash Flow | -$80,282 | -$150,077 | -$109,900 | -$56,539 |